NeuroMetrix, Inc. (NURO)
May 1, 2025 - NURO was delisted (reason: acquired by ECOR)
4.580
0.00 (0.00%)
Inactive · Last trade price on May 1, 2025

NeuroMetrix Statistics

Total Valuation

Market Cap n/a
Enterprise Value n/a

Important Dates

The last earnings date was Wednesday, May 14, 2025, after market close.

Earnings Date May 14, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +89.05%
Shares Change (QoQ) +0.90%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 14.83, with a Debt / Equity ratio of 0.01.

Current Ratio 14.83
Quick Ratio 13.12
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -45.38% and return on invested capital (ROIC) is -29.50%.

Return on Equity (ROE) -45.38%
Return on Assets (ROA) -27.90%
Return on Invested Capital (ROIC) -29.50%
Return on Capital Employed (ROCE) -57.31%
Revenue Per Employee $233,295
Profits Per Employee -$600,466
Employee Count13
Asset Turnover 0.17
Inventory Turnover 0.91

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +4.81% in the last 52 weeks. The beta is 1.84, so NeuroMetrix's price volatility has been higher than the market average.

Beta (5Y) 1.84
52-Week Price Change +4.81%
50-Day Moving Average 4.40
200-Day Moving Average 4.05
Relative Strength Index (RSI) 65.80
Average Volume (20 Days) 5,334

Short Selling Information

The latest short interest is 2,269, so 0.11% of the outstanding shares have been sold short.

Short Interest 2,269
Short Previous Month 649
Short % of Shares Out 0.11%
Short % of Float 0.15%
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NeuroMetrix had revenue of $3.03 million and -$7.81 million in losses. Loss per share was -$3.96.

Revenue3.03M
Gross Profit 1.71M
Operating Income -8.20M
Pretax Income -7.81M
Net Income -7.81M
EBITDA -8.11M
EBIT -8.20M
Loss Per Share -$3.96
Full Income Statement

Balance Sheet

The company has $13.10 million in cash and $107,352 in debt, giving a net cash position of $12.99 million.

Cash & Cash Equivalents 13.10M
Total Debt 107,352
Net Cash 12.99M
Net Cash Per Share n/a
Equity (Book Value) 14.31M
Book Value Per Share 6.98
Working Capital 14.00M
Full Balance Sheet

Cash Flow

Operating Cash Flow -7.13M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 56.42%, with operating and profit margins of -270.43% and -257.38%.

Gross Margin 56.42%
Operating Margin -270.43%
Pretax Margin -257.38%
Profit Margin -257.38%
EBITDA Margin -267.33%
EBIT Margin -270.43%
FCF Margin n/a

Dividends & Yields

NeuroMetrix does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -89.05%
Shareholder Yield -89.05%
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

NeuroMetrix has an Altman Z-Score of -16.13 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -16.13
Piotroski F-Score 1